Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.42M 1.33M 1.21M 2.29M 156M 2.32M 15.61M 6.11M 78.32M 6.16M 6.03M 261M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.04M 6.59M 6.02M 11.32M 775M 11.51M 77.33M 30.3M 388M 30.52M 29.86M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
-0.67%+9.62%+92.54%+131.51% 1,098B
-0.57%+1.91%+49.46%+49.44% 631B
+0.90%+2.48%+25.78%+64.17% 438B
-1.13%+3.13%+49.78%+39.13% 368B
-0.74%+1.01%+31.08%+38.64% 298B
-1.22%+0.89%+7.32%+7.38% 251B
-0.78%+6.25%+45.36%+57.86% 226B
+0.34%-0.13%-4.77%-50.50% 209B
+2.49%+0.78%+13.14%+70.38% 165B
Average -10.04%+1,657.21%+34.41%+45.34% 409.37B
Weighted average by Cap. -0.33%+1,331.50%+50.20%+66.66%

Financials

2007 2008
Net sales 23.47M 20.34M 19.04M 17.37M 32.69M 2.24B 33.24M 223M 87.46M 1.12B 88.11M 86.19M 3.74B 25.96M 22.5M 21.06M 19.22M 36.16M 2.48B 36.77M 247M 96.75M 1.24B 97.47M 95.35M 4.13B
Net income -20.86M -18.08M -16.92M -15.44M -29.05M -1.99B -29.54M -198M -77.74M -996M -78.32M -76.61M -3.32B -4.01M -3.47M -3.25M -2.97M -5.58M -382M -5.67M -38.11M -14.93M -191M -15.04M -14.71M -638M
Net Debt 18.79M 16.28M 15.24M 13.91M 26.17M 1.79B 26.61M 179M 70.03M 897M 70.55M 69.01M 2.99B 6.49M 5.62M 5.26M 4.8M 9.04M 619M 9.19M 61.72M 24.18M 310M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-